News | April 15, 2007

William Beaumont, Arizona Heart Complete First Endoluminal Stent Graft Procedures with Endologix Delivery Device

April 16, 2007 - Endologix, Inc. has announced the first three successful implantations of the Powerlink endoluminal stent graft (ELG) incorporating the Visiflex SurePass Delivery System.

The Visiflex SurePass is the company's next-generation delivery device that allows physicians continued guide wire access to the contralateral limb of the unibody Powerlink ELG device.

The first procedure was completed at William Beaumont Hospital in Royal Oak, MI., and two additional procedures were completed at the Arizona Heart Hospital in Phoenix, AZ.

* Venkatesh G. Ramaiah, M.D., director of vascular and endovascular research at the Arizona Heart Institute, reported, "The SurePass Delivery System further improves upon a delivery technology that is already state-of-the-art in terms of ease of deployment."
* Grayson Wheatley III, M.D., from the Arizona Heart Institute, remarked, "It exceeded my expectations and in this particular case facilitated access to a difficult contralateral limb in a tortuous anatomy."
* O. W. Brown, M.D., from the William Beaumont Hospital, commented, "The technology performed beyond my expectations and I believe the SurePass will further simplify and broaden the applications for Powerlink."

The Visiflex SurePass Delivery System replaces the contralateral limb wire with a hollow guidewire capable of accommodating a standard 0.014 guidewire. The physician can insert the guidewire prior to limb deployment in order to control and maintain access. In patients with complex iliac anatomy physicians often perform adjunctive balloon angioplasty or deliver an extension, which requires the use of a guidewire.

For more information visit

Related Content

Endologix Ends Unrestricted Sales and Use of Nellix System
News | Stent Grafts | January 07, 2019
January 7, 2019 — Endologix Inc.
Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018
Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for...
FDA Committee Votes in Favor of Incraft AAA Stent Graft System
News | Stent Grafts | June 13, 2018
Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable...
First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
FDA Concerned About Increase in stent graft Endovascular Type III Leaks
News | Stent Grafts | October 09, 2017
October 9, 2017 — The U.S.
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts | July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
News | Stent Grafts | April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts | January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts | January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts | January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
Overlay Init